Manhattan BioSolutions establishes new laboratory space at the JLabs JNJ Innovation incubator in New York City

Collaboration with National Institutes of Health and Binghamton University to Develop Novel Antibody-Drug Conjugates for Pediatric Cancer New York City, New York […]

New York City, New York Jun 29, 2021 (Issuewire.com)  – EVQLV, an innovator in developing artificial intelligence to accelerate how biologic therapies reach patients, […]

NEW YORK, NY / ACCESSWIRE / June 1, 2022 / Manhattan BioSolutions, Inc., an emerging biotechnology company developing new classes of therapeutic biologics […]